{"id":48459,"date":"2022-09-15T22:01:40","date_gmt":"2022-09-15T20:01:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/"},"modified":"2022-09-15T22:01:40","modified_gmt":"2022-09-15T20:01:40","slug":"valent-biosciences-promotes-salman-mir-to-evp-and-coo","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/","title":{"rendered":"Valent BioSciences Promotes Salman Mir to EVP and COO"},"content":{"rendered":"<div>\n<p>LIBERTYVILLE, Ill.&#8211;(BUSINESS WIRE)&#8211;Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forestry, has announced the promotion of Salman Mir to Executive Vice President and Chief Operating Officer. He will continue reporting to Ted Melnik, Valent BioSciences\u2019 President and Chief Executive Officer.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220915006077\/en\/1573588\/5\/Salman_Mir_Headshot.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220915006077\/en\/1573588\/21\/Salman_Mir_Headshot.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20220915006077\/en\/669932\/5\/Valent_Bio_Logo_Hi_Resolution_NoBackground.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220915006077\/en\/669932\/21\/Valent_Bio_Logo_Hi_Resolution_NoBackground.jpg\"><\/a><\/p>\n<p>\nIn his new position, Mir will oversee the entire spectrum of Valent BioSciences activities worldwide. He will also work closely with the organization\u2019s leadership team to execute plans for continued strong business growth and maintain a focus on innovation to support all of parent company Sumitomo Chemical Co., Ltd.\u2019s Health and Crop Sciences business\u2019 commercial objectives<i>.<\/i>\n<\/p>\n<p>\nMir has extensive experience in sales, marketing, operations, and business development roles with major global crop protection companies. He joined Valent BioSciences in 2012 as Vice President of Global Marketing and Business Management, where he was responsible for leading the company\u2019s global marketing and commercial activities.\n<\/p>\n<p>\nIn 2016, Mir moved to Sumitomo Chemical\u2019s AgroSolutions Division International (ASDI) for an overseas assignment. During his tenure there, he was Head of AgroSolutions Division International (Asia Pacific) and General Manager Sumitomo Chemical Asia (SCA). He returned to the U.S. in 2019 to serve as Chief Operating Officer of Valent BioSciences subsidiary Pace International LLC in Wapato, Washington. In early 2021, he began leading the Global Sustainable Solutions Business Unit (SSBU) team in partnership with Sumitomo Chemical affiliates around the world and also assumed the new position of Chief Commercial Officer for Valent BioSciences.\n<\/p>\n<p>\nMir holds an undergraduate Veterinary Sciences degree from the University of Veterinary and Animal Sciences and earned his Master\u2019s degree in Business Administration from Lahore University of Management Sciences, Pakistan.\n<\/p>\n<p>\n<b>About Valent BioSciences LLC<\/b>\n<\/p>\n<p>\nHeadquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.valentbiosciences.com&amp;esheet=52908662&amp;newsitemid=20220915006077&amp;lan=en-US&amp;anchor=www.valentbiosciences.com&amp;index=1&amp;md5=90a024fc4c9f7392a54ce5bc24b1c628\" rel=\"nofollow noopener\" shape=\"rect\">www.valentbiosciences.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nJohn Mandel<br \/>\n<br \/>Valent BioSciences LLC<br \/>\n<br \/>847-968-4728<br \/>\n<br \/>Email: <a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#58;&#x6a;&#x6f;h&#110;&#46;&#x6d;&#x61;n&#100;&#x65;&#x6c;&#x40;v&#97;&#x6c;&#x65;n&#116;&#98;&#x69;&#x6f;s&#99;&#105;&#x65;&#x6e;c&#101;&#x73;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#106;&#111;&#x68;n&#46;&#x6d;&#x61;n&#100;&#x65;&#x6c;&#64;&#118;&#x61;&#x6c;e&#110;&#x74;&#x62;i&#111;&#x73;&#x63;i&#101;&#x6e;c&#101;&#115;&#x2e;c&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>LIBERTYVILLE, Ill.&#8211;(BUSINESS WIRE)&#8211;Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forestry, has announced the promotion of Salman Mir to Executive Vice President and Chief Operating Officer. He will continue reporting to Ted Melnik, Valent BioSciences\u2019 President and Chief Executive Officer. In his new position, Mir will oversee the entire spectrum &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48459","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Valent BioSciences Promotes Salman Mir to EVP and COO - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valent BioSciences Promotes Salman Mir to EVP and COO - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LIBERTYVILLE, Ill.&#8211;(BUSINESS WIRE)&#8211;Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forestry, has announced the promotion of Salman Mir to Executive Vice President and Chief Operating Officer. He will continue reporting to Ted Melnik, Valent BioSciences\u2019 President and Chief Executive Officer. In his new position, Mir will oversee the entire spectrum ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-15T20:01:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220915006077\/en\/1573588\/21\/Salman_Mir_Headshot.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Valent BioSciences Promotes Salman Mir to EVP and COO\",\"datePublished\":\"2022-09-15T20:01:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/\"},\"wordCount\":357,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915006077\\\/en\\\/1573588\\\/21\\\/Salman_Mir_Headshot.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/\",\"name\":\"Valent BioSciences Promotes Salman Mir to EVP and COO - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915006077\\\/en\\\/1573588\\\/21\\\/Salman_Mir_Headshot.jpg\",\"datePublished\":\"2022-09-15T20:01:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915006077\\\/en\\\/1573588\\\/21\\\/Salman_Mir_Headshot.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915006077\\\/en\\\/1573588\\\/21\\\/Salman_Mir_Headshot.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Valent BioSciences Promotes Salman Mir to EVP and COO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valent BioSciences Promotes Salman Mir to EVP and COO - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/","og_locale":"en_US","og_type":"article","og_title":"Valent BioSciences Promotes Salman Mir to EVP and COO - Pharma Trend","og_description":"LIBERTYVILLE, Ill.&#8211;(BUSINESS WIRE)&#8211;Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forestry, has announced the promotion of Salman Mir to Executive Vice President and Chief Operating Officer. He will continue reporting to Ted Melnik, Valent BioSciences\u2019 President and Chief Executive Officer. In his new position, Mir will oversee the entire spectrum ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-15T20:01:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220915006077\/en\/1573588\/21\/Salman_Mir_Headshot.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Valent BioSciences Promotes Salman Mir to EVP and COO","datePublished":"2022-09-15T20:01:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/"},"wordCount":357,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220915006077\/en\/1573588\/21\/Salman_Mir_Headshot.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/","url":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/","name":"Valent BioSciences Promotes Salman Mir to EVP and COO - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220915006077\/en\/1573588\/21\/Salman_Mir_Headshot.jpg","datePublished":"2022-09-15T20:01:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220915006077\/en\/1573588\/21\/Salman_Mir_Headshot.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220915006077\/en\/1573588\/21\/Salman_Mir_Headshot.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/valent-biosciences-promotes-salman-mir-to-evp-and-coo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Valent BioSciences Promotes Salman Mir to EVP and COO"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48459"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48459\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}